The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.
about
Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal InfectionsChanges of serum aspergillus galactomannan during hematopoietic stem cell transplantation in children with prior invasive aspergillosis.Development and Evaluation of a Loop-Mediated Isothermal Amplification Method for Rapid Detection of Aspergillus fumigatusUse of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.Proteomics as a Tool to Identify New Targets Against Aspergillus and Scedosporium in the Context of Cystic Fibrosis.Galactofuranose antigens, a target for diagnosis of fungal infections in humans.The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study.
P2860
Q30244009-F9D7F098-72EB-42B5-B453-A218258F83E2Q31111038-63DB6163-0A31-41CB-8FA8-EAC42DDE565AQ36125981-34DDF438-4AE8-4263-B2C9-80F5127C581DQ36668077-01A44147-25C5-44F9-9E9C-07A68ACEDCFCQ36734900-691BDBBE-EA20-4F86-A7F4-73C3BC3264D6Q38965488-887DBB2B-FC0F-4045-BEAA-41DFBADAF24BQ39292920-63343CB8-EF0A-462C-963F-067B04A05609Q40061239-89179729-D7C5-4C6B-9083-6355F685C882Q49591743-7DE1295E-2EC0-40F9-81D3-108908CF3C24
P2860
The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The use of biomarkers and mole ...... in immunocompromised patients.
@en
type
label
The use of biomarkers and mole ...... in immunocompromised patients.
@en
prefLabel
The use of biomarkers and mole ...... in immunocompromised patients.
@en
P2093
P2860
P356
P1433
P1476
The use of biomarkers and mole ...... in immunocompromised patients.
@en
P2093
Anshula Ambasta
Deirdre L Church
Julie Carson
P2860
P304
P356
10.1093/MMY/MYV026
P577
2015-05-30T00:00:00Z